MGC Pharmaceuticals Ltd (ASX:MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines.
The company is focused on its core business of executing its growth strategy and become a world-leading, vertically integrated, biopharma company focused on the development and production of phytocannabinoid derived medications for targeted global markets.
London's cannabis sector is finally budding two decades after GW Pharma blazed a trail, with debutants MGC Pharmaceuticals and Kanabo Group both warmly welcomed after listing this month
Director Interviews
MGC Pharmaceuticals get set for LSE debut as first medicinal cannabis company listed on main market
Small caps
MGC Pharma's new head of global sales has big ambitions and says they're 'ready to go'
